Trials / Unknown
UnknownNCT05837065
Prognostic Models for HCC Based on Tumor Micronecrosis
Development and Validation of Novel Models Including Tumor Micronecrosis for Predicting the Postoperative Survival of Patients With Hepatocellular Carcinoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 765 (estimated)
- Sponsor
- Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The heterogeneity of hepatocellular carcinoma (HCC) leads to the unsatisfying predicting performance of current staging systems. HCC patients with pathological tumor micronecrosis have immunosuppressive microenvironment. We aimed to develop novel prognostic models by integrating micronecrosis to more precisely predict the survival of HCC patients after hepatectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | observing whether HCC patients having tumor micronecrosis | whether HCC patients having tumor micronecrosis or not |
Timeline
- Start date
- 2022-09-15
- Primary completion
- 2023-03-30
- Completion
- 2023-12-30
- First posted
- 2023-05-01
- Last updated
- 2023-05-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05837065. Inclusion in this directory is not an endorsement.